US Stock MarketDetailed Quotes

KALV KalVista Pharmaceuticals

Watchlist

8.530
-0.300-3.40%

Close Dec 27 16:00 ET

8.530
0.0000.00%

Post 20:01 ET

421.54MMarket Cap-2.32P/E (TTM)

KalVista Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Oct 31, 2024

(Q1)Jul 31, 2024

(FY)Apr 30, 2024

(Q4)Apr 30, 2024

(Q3)Jan 31, 2024

(Q2)Oct 31, 2023

(Q1)Jul 31, 2023

(FY)Apr 30, 2023

(Q4)Apr 30, 2023

(Q3)Jan 31, 2023

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-99.96%-39.64M

-50.47%-40.22M

-18.56%-89.23M

33.27%-15.11M

-196.81%-27.57M

3.73%-19.83M

-17.54%-26.73M

3.68%-75.26M

15.50%-22.64M

33.96%-9.29M

Net income from continuing operations

-52.86%-42.27M

-59.75%-40.44M

-36.31%-126.64M

-69.74%-44.65M

-36.26%-29.03M

-24.23%-27.65M

-9.87%-25.32M

-12.83%-92.91M

-9.09%-26.31M

5.19%-21.3M

Operating gains losses

-226.68%-774K

-3.10%-731K

61.80%-565K

86.16%-31K

27.45%-436K

155.75%611K

-260.41%-709K

-169.34%-1.48M

-119.67%-224K

-198.85%-601K

Depreciation and amortization

15.23%227K

16.06%224K

13.65%816K

16.49%219K

4.02%207K

13.87%197K

22.15%193K

27.30%718K

20.51%188K

33.56%199K

Other non cash items

-136.84%-45K

-183.33%-5K

-114.29%-12K

-103.13%-1K

-80.00%2K

-200.00%-19K

-73.91%6K

-53.07%84K

23.08%32K

-90.65%10K

Change In working capital

-94.41%213K

45.25%-2.31M

104.60%15.17M

1,364.73%16.61M

-110.47%-1.03M

1,784.96%3.81M

-25.72%-4.22M

160.16%7.41M

115.89%1.13M

140.22%9.86M

-Change in receivables

47.26%-1.07M

39.88%-1.25M

453.02%8.18M

429.69%14.39M

-122.93%-2.11M

43.23%-2.03M

41.62%-2.08M

55.47%-2.32M

-17.21%-4.37M

59.06%9.19M

-Change in prepaid assets

19.27%2.1M

21.93%-783K

-108.04%-538K

-164.18%-1.44M

-81.65%145K

2.86%1.76M

-151.83%-1M

172.09%6.69M

140.03%2.25M

163.71%790K

-Change in payables and accrued expense

-120.23%-823K

75.80%-274K

147.75%7.53M

12.74%3.66M

907.83%929K

150.25%4.07M

34.22%-1.13M

40.76%3.04M

47.01%3.25M

73.26%-115K

Cash from discontinued investing activities

Operating cash flow

-99.96%-39.64M

-50.47%-40.22M

-18.56%-89.23M

33.27%-15.11M

-196.81%-27.57M

3.73%-19.83M

-17.54%-26.73M

3.68%-75.26M

15.50%-22.64M

33.96%-9.29M

Investing cash flow

Cash flow from continuing investing activities

70.45%48.67M

89.48%37.16M

-304.56%-84.72M

-1,931.98%-126.19M

-166.27%-6.7M

42.08%28.56M

-34.72%19.61M

-28.42%41.42M

-149.94%-6.21M

-119.51%-2.52M

Capital expenditure reported

53.69%-94K

---64K

---401K

----

---203K

--0

----

Net PPE purchase and sale

-5,300.00%-108K

-250.00%-21K

96.49%-42K

78.26%-15K

-26.67%-19K

98.96%-2K

99.35%-6K

-28.46%-1.2M

19.77%-69K

92.57%-15K

Net intangibles purchase and sale

----

--0

Net investment purchase and sale

69.93%48.88M

89.85%37.25M

-297.78%-84.28M

-1,952.83%-126.06M

-163.47%-6.59M

41.75%28.76M

-36.64%19.62M

-27.52%42.61M

-149.05%-6.14M

-119.09%-2.5M

Cash from discontinued investing activities

Investing cash flow

70.45%48.67M

89.48%37.16M

-304.56%-84.72M

-1,931.98%-126.19M

-166.27%-6.7M

42.08%28.56M

-34.72%19.61M

-28.42%41.42M

-149.94%-6.21M

-119.51%-2.52M

Financing cash flow

Cash flow from continuing financing activities

130.47%295K

1,370.59%3M

159.33%150.71M

454,942.42%150.1M

-99.51%284K

-23.81%128K

21.43%204K

3,575.90%58.12M

-123.91%-33K

7,388.73%57.81M

Net common stock issuance

----

71.34%96.95M

--96.95M

----

--56.58M

--0

----

Proceeds from stock option exercised by employees

130.47%295K

1,370.59%3M

3,405.15%53.77M

161,169.70%53.15M

-76.93%284K

-23.81%128K

21.43%204K

-2.97%1.53M

-123.91%-33K

59.46%1.23M

Cash from discontinued financing activities

Financing cash flow

130.47%295K

1,370.59%3M

159.33%150.71M

454,942.42%150.1M

-99.51%284K

-23.81%128K

21.43%204K

3,575.90%58.12M

-123.91%-33K

7,388.73%57.81M

Net cash flow

Beginning cash position

-35.54%31.85M

-43.47%31.79M

82.99%56.24M

-72.89%23.06M

49.45%57.67M

30.49%49.41M

82.99%56.24M

-39.26%30.73M

86.61%85.05M

-17.01%38.59M

Current changes in cash

5.27%9.33M

99.16%-58K

-195.74%-23.24M

130.50%8.81M

-173.88%-33.99M

2,800.91%8.86M

-192.54%-6.91M

229.83%24.27M

-103.13%-28.88M

11,866.50%46.01M

Effect of exchange rate changes

167.61%407K

39.29%117K

-198.14%-1.21M

-208.82%-74K

-235.89%-621K

-157.33%-602K

124.78%84K

205.91%1.24M

110.83%68K

187.38%457K

End cash Position

-27.89%41.58M

-35.54%31.85M

-43.47%31.79M

-72.89%23.06M

49.45%57.67M

30.49%49.41M

82.99%56.24M

86.61%85.05M

Free cash flow

-98.92%-39.84M

-50.75%-40.31M

-17.29%-89.67M

32.94%-15.23M

-197.52%-27.68M

3.64%-20.03M

-12.99%-26.74M

3.30%-76.46M

15.52%-22.71M

34.79%-9.3M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Oct 31, 2024	(Q1)Jul 31, 2024	(FY)Apr 30, 2024	(Q4)Apr 30, 2024	(Q3)Jan 31, 2024	(Q2)Oct 31, 2023	(Q1)Jul 31, 2023	(FY)Apr 30, 2023	(Q4)Apr 30, 2023	(Q3)Jan 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-99.96%-39.64M	-50.47%-40.22M	-18.56%-89.23M	33.27%-15.11M	-196.81%-27.57M	3.73%-19.83M	-17.54%-26.73M	3.68%-75.26M	15.50%-22.64M	33.96%-9.29M
Net income from continuing operations	-52.86%-42.27M	-59.75%-40.44M	-36.31%-126.64M	-69.74%-44.65M	-36.26%-29.03M	-24.23%-27.65M	-9.87%-25.32M	-12.83%-92.91M	-9.09%-26.31M	5.19%-21.3M
Operating gains losses	-226.68%-774K	-3.10%-731K	61.80%-565K	86.16%-31K	27.45%-436K	155.75%611K	-260.41%-709K	-169.34%-1.48M	-119.67%-224K	-198.85%-601K
Depreciation and amortization	15.23%227K	16.06%224K	13.65%816K	16.49%219K	4.02%207K	13.87%197K	22.15%193K	27.30%718K	20.51%188K	33.56%199K
Other non cash items	-136.84%-45K	-183.33%-5K	-114.29%-12K	-103.13%-1K	-80.00%2K	-200.00%-19K	-73.91%6K	-53.07%84K	23.08%32K	-90.65%10K
Change In working capital	-94.41%213K	45.25%-2.31M	104.60%15.17M	1,364.73%16.61M	-110.47%-1.03M	1,784.96%3.81M	-25.72%-4.22M	160.16%7.41M	115.89%1.13M	140.22%9.86M
-Change in receivables	47.26%-1.07M	39.88%-1.25M	453.02%8.18M	429.69%14.39M	-122.93%-2.11M	43.23%-2.03M	41.62%-2.08M	55.47%-2.32M	-17.21%-4.37M	59.06%9.19M
-Change in prepaid assets	19.27%2.1M	21.93%-783K	-108.04%-538K	-164.18%-1.44M	-81.65%145K	2.86%1.76M	-151.83%-1M	172.09%6.69M	140.03%2.25M	163.71%790K
-Change in payables and accrued expense	-120.23%-823K	75.80%-274K	147.75%7.53M	12.74%3.66M	907.83%929K	150.25%4.07M	34.22%-1.13M	40.76%3.04M	47.01%3.25M	73.26%-115K
Cash from discontinued investing activities
Operating cash flow	-99.96%-39.64M	-50.47%-40.22M	-18.56%-89.23M	33.27%-15.11M	-196.81%-27.57M	3.73%-19.83M	-17.54%-26.73M	3.68%-75.26M	15.50%-22.64M	33.96%-9.29M
Investing cash flow
Cash flow from continuing investing activities	70.45%48.67M	89.48%37.16M	-304.56%-84.72M	-1,931.98%-126.19M	-166.27%-6.7M	42.08%28.56M	-34.72%19.61M	-28.42%41.42M	-149.94%-6.21M	-119.51%-2.52M
Capital expenditure reported	53.69%-94K	---64K	---401K	----	----	---203K	--0	--0	----	----
Net PPE purchase and sale	-5,300.00%-108K	-250.00%-21K	96.49%-42K	78.26%-15K	-26.67%-19K	98.96%-2K	99.35%-6K	-28.46%-1.2M	19.77%-69K	92.57%-15K
Net intangibles purchase and sale	----	----	----	----	----	----	----	----	----	--0
Net investment purchase and sale	69.93%48.88M	89.85%37.25M	-297.78%-84.28M	-1,952.83%-126.06M	-163.47%-6.59M	41.75%28.76M	-36.64%19.62M	-27.52%42.61M	-149.05%-6.14M	-119.09%-2.5M
Cash from discontinued investing activities
Investing cash flow	70.45%48.67M	89.48%37.16M	-304.56%-84.72M	-1,931.98%-126.19M	-166.27%-6.7M	42.08%28.56M	-34.72%19.61M	-28.42%41.42M	-149.94%-6.21M	-119.51%-2.52M
Financing cash flow
Cash flow from continuing financing activities	130.47%295K	1,370.59%3M	159.33%150.71M	454,942.42%150.1M	-99.51%284K	-23.81%128K	21.43%204K	3,575.90%58.12M	-123.91%-33K	7,388.73%57.81M
Net common stock issuance	----	----	71.34%96.95M	--96.95M	----	----	----	--56.58M	--0	----
Proceeds from stock option exercised by employees	130.47%295K	1,370.59%3M	3,405.15%53.77M	161,169.70%53.15M	-76.93%284K	-23.81%128K	21.43%204K	-2.97%1.53M	-123.91%-33K	59.46%1.23M
Cash from discontinued financing activities
Financing cash flow	130.47%295K	1,370.59%3M	159.33%150.71M	454,942.42%150.1M	-99.51%284K	-23.81%128K	21.43%204K	3,575.90%58.12M	-123.91%-33K	7,388.73%57.81M
Net cash flow
Beginning cash position	-35.54%31.85M	-43.47%31.79M	82.99%56.24M	-72.89%23.06M	49.45%57.67M	30.49%49.41M	82.99%56.24M	-39.26%30.73M	86.61%85.05M	-17.01%38.59M
Current changes in cash	5.27%9.33M	99.16%-58K	-195.74%-23.24M	130.50%8.81M	-173.88%-33.99M	2,800.91%8.86M	-192.54%-6.91M	229.83%24.27M	-103.13%-28.88M	11,866.50%46.01M
Effect of exchange rate changes	167.61%407K	39.29%117K	-198.14%-1.21M	-208.82%-74K	-235.89%-621K	-157.33%-602K	124.78%84K	205.91%1.24M	110.83%68K	187.38%457K
End cash Position	-27.89%41.58M	-35.54%31.85M	-43.47%31.79M	-43.47%31.79M	-72.89%23.06M	49.45%57.67M	30.49%49.41M	82.99%56.24M	82.99%56.24M	86.61%85.05M
Free cash flow	-98.92%-39.84M	-50.75%-40.31M	-17.29%-89.67M	32.94%-15.23M	-197.52%-27.68M	3.64%-20.03M	-12.99%-26.74M	3.30%-76.46M	15.52%-22.71M	34.79%-9.3M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Heat List

Overall

No Data